Welcome to our dedicated page for Algorhythm Holdings SEC filings (Ticker: RIME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Algorhythm Holdings, Inc. (NASDAQ: RIME) SEC filings page on Stock Titan brings together the company’s regulatory disclosures, including Forms 10-K, 10-Q, 8-K, proxy statements, and registration statements. Algorhythm is a smaller reporting company that has transitioned into an AI logistics and distribution business centered on SemiCab, and its filings provide detailed insight into this transformation, its capital structure, and its risk profile.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, investors can review Algorhythm’s financial statements, segment information related to SemiCab, and discussions of material weaknesses, liquidity, and operating performance. Current reports on Form 8-K document key events such as the sale of the legacy Singing Machine karaoke business, the acquisition of SMCB Solutions Private Limited to expand SemiCab in India, the launch of the Apex SaaS platform, changes in independent registered public accounting firms, director and officer appointments and resignations, and stockholder votes on matters like reverse stock split authority, reincorporation, and equity incentive plan amendments.
Registration statements on Form S-1 and S-1/A describe Algorhythm’s arrangements with investors such as Streeterville Capital, LLC, including pre-paid purchase structures, commitment shares, and resale registration for common stock and warrants. These documents outline potential dilution, use of proceeds, and the company’s status as a smaller reporting company. Proxy materials on Schedule 14A provide additional context on corporate governance, board composition, and stockholder proposals.
On Stock Titan, Algorhythm’s filings are supplemented with AI-powered summaries that explain the significance of lengthy documents, highlight major changes from prior periods, and flag items that may affect shareholders, such as financing terms, auditor changes, and governance actions. Real-time updates from EDGAR ensure that new 8-Ks, 10-Qs, and 10-Ks appear promptly, while Form 4 insider transaction reports, when filed, can help users track equity awards and share activity by directors and officers. By using these tools, investors can navigate Algorhythm’s evolving AI logistics strategy, capital markets activity, and compliance record without reading every line of each filing.
Algorhythm Holdings, Inc. entered into a Settlement Agreement with Continuation Capital, Inc. covering liabilities with a principal Claim Amount of $1,928,014. Algorhythm agreed to issue Continuation Capital up to 5,000,000 shares of common stock in tranches until Continuation Capital has generated aggregate proceeds equal to 120% of the Claim Amount. A Florida state court approved the Settlement Agreement after a fairness hearing pursuant to Section 3(a)(10) of the Securities Act. The stock issuances are structured as private placements exempt from registration under that section, completed without underwriting discounts, commissions, advertising or general solicitation, and Continuation Capital’s holdings are capped at 19.99% of Algorhythm’s outstanding common stock.
The company also entered into amended and restated employment agreements with CEO Gary Atkinson and CFO and General Counsel Alex Andre. These contracts harmonize their Change of Control treatment by granting, each time such an event occurs, a lump-sum bonus equal to the executive’s Base Salary and Annual Bonus for that year, and include provisions intended to help ensure compliance with Internal Revenue Code Sections 280G, 4999 and 409A.
Algorhythm Holdings, Inc. restructured part of its financing with Streeterville Capital by exchanging a $3,500,000 partitioned portion of its Secured Pre-Paid Purchase #4 for 3,500 shares of newly created Series A Preferred Stock. This reduced the outstanding balance of Secured Pre-Paid Purchase #4 to $7,202,371.69.
The company filed a Certificate of Designation creating 15,000 Series A Preferred shares with a stated value of $1,150 each, accruing a 9% annual preferred return, compounding daily and payable quarterly in cash or additional preferred shares. The Series A Preferred ranks senior to common stock for dividends and liquidation and includes covenants restricting certain issuances, corporate actions and asset transactions, modifying the rights of existing common stockholders.
Algorhythm Holdings, Inc. entered into a second forbearance agreement with SemiCab, Inc. covering a $1,750,000 promissory note issued under an equity purchase agreement. The note required an Initial Payment of $1,500,000 on May 2, 2026, which the company did not pay on that date.
The new forbearance agreement dated June 16, 2026 confirms the Seller’s irrevocable waiver of any default or event of default arising from the missed Initial Payment and extends the period during which the Seller will forbear from taking action related to that nonpayment through July 16, 2026. The remaining $250,000 of principal is scheduled to be paid on November 2, 2026.
Algorhythm Holdings, Inc. has been notified by Nasdaq that its common stock no longer meets the $1.00 per share minimum bid price required for continued listing on The Nasdaq Capital Market, based on the 30 consecutive business days from May 4, 2026 to June 15, 2026.
The company has 180 calendar days, until December 14, 2026, to regain compliance. If the closing bid price is at least $1.00 for at least ten consecutive business days during this period, Nasdaq will confirm compliance. Algorhythm may qualify for an additional 180-day period if it meets other listing standards and may use tools such as a reverse stock split to attempt to restore compliance. The notice does not immediately affect trading, and the stock will continue to trade under the symbol RIME while the company evaluates options.
Algorhythm Holdings, Inc. is registering up to 10,000,000 shares of common stock for resale by Streeterville Capital, LLC. These shares may be issued to Streeterville under prepaid purchase agreements between the parties. The offering is a resale by the selling stockholder; the company will receive no proceeds from sales by Streeterville.
The prospectus states there were 15,425,958 shares outstanding as of the date of this prospectus. Streeterville previously purchased shares by exercising its purchase rights (12,077,557 shares issued to date). Aggregate obligations owed to Streeterville total $21,285,000, with approximately $701,000 outstanding under the first Pre-Paid Purchase and $10,355,000 outstanding under the fourth Pre-Paid Purchase. Streeterville is limited to beneficial ownership of 9.99% and resale plans must comply with Nasdaq Listing Rule 5635(d).
Algorhythm Holdings, Inc. is registering up to 10,000,000 shares of common stock for resale by Streeterville Capital, LLC. These shares may be issued under a Securities Purchase Agreement that allows Streeterville to fund pre-paid share purchases up to an aggregate principal amount of $20,000,000.
Algorhythm has completed four Pre-Paid Purchases totaling $19,500,000 in principal, creating $21,285,000 of obligations, of which $10,229,000 has been repaid through Streeterville’s prior purchase of 12,077,557 shares. The company will not receive proceeds from Streeterville’s resale of the registered shares, though any future share purchases by Streeterville will reduce outstanding pre-paid balances. Streeterville’s ownership is limited to 9.99% of Algorhythm’s outstanding stock, and issuances must comply with Nasdaq Listing Rule 5635(d). As of this prospectus, Algorhythm has 15,425,958 shares outstanding, with a Nasdaq Capital Market listing under the symbol “RIME.”
Algorhythm Holdings, Inc. reports that it has regained compliance with Nasdaq’s minimum stockholders’ equity requirement for continued listing. Nasdaq Listing Rule 5550(b)(1) requires stockholders’ equity of at least $2,500,000, and the company reported stockholders’ equity of $3,168,000 in its Form 10-Q for the quarter ended March 31, 2026.
The company states that equity improved by cutting operating expenses, increasing net sales in its SemiCab business, and selling common stock to Streeterville Capital, LLC under an August 21, 2025 securities purchase agreement that repaid various pre-paid purchases. Nasdaq previously granted extra time to regain compliance and will continue monitoring; failure to remain compliant in future periodic reports could still lead to delisting.
Algorhythm Holdings, Inc. (RIME) reported a Q1 2026 net loss of $5.4 million from continuing operations on $2.4 million of net sales, up sharply from $123,000 a year earlier. Despite strong revenue growth and a smaller loss than the prior-year period, gross margin remained negative as cost of sales of $3.1 million exceeded revenue.
The company ended March 31, 2026 with $10.9 million of cash and restricted cash and total assets of $18.5 million, but carried $15.3 million of liabilities, including $9.5 million of promissory notes and $2.3 million of related-party debt. Management disclosed that existing cash will not fund planned operations for one year and concluded that substantial doubt exists about the company’s ability to continue as a going concern.
Algorhythm has shifted fully into its SemiCab AI-enabled logistics platform after selling the Singing Machine karaoke business, and is relying heavily on structured financings. In Q1 2026 it raised cash through multiple high-cost promissory notes and pre-paid share purchase facilities with Streeterville Capital, including a fourth pre-paid purchase with $10.4 million of principal, while issuing over 10.7 million shares to settle prepaid purchase obligations and recognizing $923,000 of stock-based compensation.
Algorhythm Holdings, Inc. CFO & General Counsel Andre Alex updated his equity compensation through cancellations and a new stock option grant. A previously granted restricted stock award for 23,818 common shares and a non-qualified stock option for 23,818 shares at $2.78 per share were cancelled and returned to the issuer. In exchange, he received a new non-qualified stock option for 47,636 common shares at an exercise price of $0.76 per share under the 2022 Equity Incentive Plan, with vesting over time. Following these transactions he held no common stock directly and 209,973 stock options in total, reflecting a restructuring of his awards rather than any open-market buying or selling.